|
Ramirez-Macias I, Orenes-Pinero E, Camelo-Castillo A, Rivera-Caravaca JM, Lopez-Garcia C, Marin F. Novel insights in the relationship of gut microbiota and coronary artery diseases. Crit Rev Food Sci Nutr. 2022;62(14):3738-3750. doi: 10.1080/10408398.2020.1868397. Epub 2021 Jan 5. PubMed PMID: 33399007.
AÑO: 2022; IF: 10.2
|
33399007
|
Roldan V, Martinez-Montesinos L, Lopez-Galvez R, Garcia-Tomas L, Lip GYH, Rivera-Caravaca JM, Marin F. Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists. J Pers Med. 2022 Mar 17;12(3):487. doi: 10.3390/jpm12030487. PubMed PMID: 35330486; PubMed Central PMCID: PMC8954236.
AÑO: 2022; IF: 3.508
|
|
Rivera-Caravaca JM, Lip GYH, Roldan V, Marin F. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. Front Cardiovasc Med. 2022 Oct 17;9:1042728. doi: 10.3389/fcvm.2022.1042728. eCollection 2022. No abstract available. PubMed PMID: 36324744; PubMed Central PMCID: PMC9619039.
AÑO: 2022; IF: 3.6
|
|
Ding WY, Rivera-Caravaca JM, Marin F, Li G, Roldan V, Lip GYH. Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence. Br J Clin Pharmacol. 2022 Jan;88(1):282-289. doi: 10.1111/bcp.14961. Epub 2021 Jul 13. PubMed PMID: 34192808.
AÑO: 2022; IF: 3.4
|
|
Rivera-Caravaca JM, Piot O, Roldan-Rabadan I, Denis A, Anguita M, Mansourati J, Perez-Cabeza A, Marijon E, Garcia-Seara J, Leclercq C, Garcia-Bolao I, Lellouche N, Potpara T, Boriani G, Fauchier L, Lip GYH, Marin F. Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry. Europace. 2022 Feb 2;24(2):202-210. doi: 10.1093/europace/euab202. PubMed PMID: 34374759.
AÑO: 2022; IF: 6.1
|